Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Histrelin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for histrelin acetate?

Histrelin acetate is the generic ingredient in three branded drugs marketed by Endo Pharm and Shire, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has three patent family members in three countries.

There are two drug master file entries for histrelin acetate. One supplier is listed for this compound.

Summary for Generic Name: histrelin acetate

Tradenames:3
Patents:2
Applicants:2
NDAs:3
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list12
Clinical Trials: see list439
Patent Applications: see list2,014
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:histrelin acetate at DailyMed

Pharmacology for Ingredient: histrelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-001Dec 24, 1991DISCNNoNo► Subscribe► Subscribe
Endo Pharm
VANTAS
histrelin acetate
IMPLANT;SUBCUTANEOUS021732-001Oct 12, 2004RXYesYes► Subscribe► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-002Dec 24, 1991DISCNNoNo► Subscribe► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-003Dec 24, 1991DISCNNoNo► Subscribe► Subscribe
Endo Pharm
SUPPRELIN LA
histrelin acetate
IMPLANT;SUBCUTANEOUS022058-001May 3, 2007RXYesYes8,062,652► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: histrelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharm
VANTAS
histrelin acetate
IMPLANT;SUBCUTANEOUS021732-001Oct 12, 20045,266,325► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-001Dec 24, 19914,244,946► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-002Dec 24, 19914,244,946► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-003Dec 24, 19914,244,946► Subscribe
Endo Pharm
SUPPRELIN LA
histrelin acetate
IMPLANT;SUBCUTANEOUS022058-001May 3, 20075,292,515► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: histrelin acetate

Country Document Number Estimated Expiration
European Patent Office1773293► Subscribe
World Intellectual Property Organization (WIPO)2006009801► Subscribe
Canada2570960► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc